BCLC staging system and therapeutic strategy

BCLC staging system and therapeutic strategy. BCLC classification comprises five stages that select the best candidates for therapies according to evidence-based data. Patients with asymptomatic early tumors (stages 0–A) are candidates for radical therapies (resection, transplantation, or local ablation). Asymptomatic patients with multinodular HCC (stage B) are suitable for transcatheter arterial chemoembolization (TACE), whereas patients with advanced symptomatic tumors and/or an invasive tumoral pattern (stage C) are candidates to receive sorafenib. End-stage disease (stage D) includes patients with poor prognosis that should be treated by best supportive care.

​

REF. UpToDate 2020.05.09